Silverarc Capital Management »

Ultragenyx Pharmaceutical In shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical In shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Ultragenyx Pharmaceutical In

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical In held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical In by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $752k 25k 30.08

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Rhythm Pharmaceuticals (RYTM)
Avidity Biosciences Ord (RNA)
Nuvalent Inc-a (NUVL)
Urogen Pharma (URGN)
Akero Therapeutics (AKRO)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Uniqure Nv SHS (QURE)
Cg Oncology (CGON)
United Therapeutics Corp Del Put Put Option
Oric Pharmaceuticals (ORIC)
Cidara Therapeutics Com New (CDTX)
Fractyl Health (GUTS)
Kalvista Pharmaceuticals (KALV)

View all positions for Silverarc Capital Management

Top funds holding Ultragenyx Pharmaceutical In

Silverarc Capital Management
Simplex Trading
Group One Trading
Jpmorgan Chase & Co

View all funds holding Ultragenyx Pharmaceutical In